These include 70,75,010 HCWs (1st dose), 37,39,478 HCWs (2nd dose), 67,92,319FLWs (1st dose) and 3,25,972 FLWs (2nd dose), 7,01,80 9beneficiaries aged more than 45 years with specific co-morbidities (1st dose) and 43,74,145 beneficiaries aged more than 60 years.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/38p5jmB
via gqrds
Subscribe to:
Post Comments (Atom)
Subscribe UsPopular Posts
|
No comments:
Post a Comment